Ledger.Open graph →
SEC Form D · filed February 14, 2025

Cyclacel Pharmaceuticals, Inc

Offering
$25.0M
Sold
—
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BERKELEY HEIGHTS, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

James C. Collins, Jr · Durham, NCDirectorAndrea C. Jackson · Durham, NCDirectorSamuel L. Barker · Berkeley Heights, NJDirectorDavid F. Natan · Berkeley Heights, NJDirectorPaul Mcbarron · Berkeley Heights, NJDirectorAvraham F. Ben-Tzvi · Berkeley Heights, NJDirectorDavid Lazar · Berkeley Heights, NJExecAvraham F. Ben-Tzvi · Berkeley Heights, NJDirectorPassco Turfway Manager, LLC · Irvine, CAExecDavid F. Natan · Berkeley Heights, NJDirectorDavid Lazar · Berkeley Heights, NJExecSpiro Rombotis · Berkeley Heights, NJDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗